T.K. Yau

1.1k total citations
18 papers, 840 citations indexed

About

T.K. Yau is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, T.K. Yau has authored 18 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Otorhinolaryngology, 10 papers in Surgery and 9 papers in Oncology. Recurrent topics in T.K. Yau's work include Head and Neck Cancer Studies (11 papers), Head and Neck Surgical Oncology (6 papers) and Breast Cancer Treatment Studies (5 papers). T.K. Yau is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Head and Neck Surgical Oncology (6 papers) and Breast Cancer Treatment Studies (5 papers). T.K. Yau collaborates with scholars based in China, United States and Hong Kong. T.K. Yau's co-authors include Anne W.M. Lee, Rebecca M.W. Yeung, Wai-Man Sze, Wai Tong Ng, W.M. Sze, Inda Soong, Joseph S. K. Au, Michael C.H. Lee, Rick Chappell and Cheuk‐Wai Choi and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

T.K. Yau

18 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.K. Yau China 11 572 453 400 244 123 18 840
Nei‐Min Chu Taiwan 15 360 0.6× 430 0.9× 459 1.1× 267 1.1× 117 1.0× 23 858
Vilija N. Avizonis United States 11 354 0.6× 300 0.7× 230 0.6× 177 0.7× 150 1.2× 11 711
W. Y. Lee China 10 501 0.9× 397 0.9× 343 0.9× 219 0.9× 44 0.4× 11 678
Mitali Dandekar India 5 707 1.2× 490 1.1× 451 1.1× 131 0.5× 97 0.8× 20 907
Sarada P. Reddy United States 12 461 0.8× 323 0.7× 317 0.8× 154 0.6× 56 0.5× 17 622
S. Racadot France 16 435 0.8× 375 0.8× 290 0.7× 330 1.4× 110 0.9× 72 863
Krzysztof Misiukiewicz United States 15 503 0.9× 343 0.8× 307 0.8× 218 0.9× 73 0.6× 68 878
Jimin Choi Australia 5 478 0.8× 309 0.7× 233 0.6× 146 0.6× 92 0.7× 5 634
Stephanie E. McClure United States 9 425 0.7× 291 0.6× 436 1.1× 321 1.3× 25 0.2× 11 727

Countries citing papers authored by T.K. Yau

Since Specialization
Citations

This map shows the geographic impact of T.K. Yau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.K. Yau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.K. Yau more than expected).

Fields of papers citing papers by T.K. Yau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.K. Yau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.K. Yau. The network helps show where T.K. Yau may publish in the future.

Co-authorship network of co-authors of T.K. Yau

This figure shows the co-authorship network connecting the top 25 collaborators of T.K. Yau. A scholar is included among the top collaborators of T.K. Yau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.K. Yau. T.K. Yau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yau, T.K., et al.. (2011). A phase II study of pemetrexed combined with cisplatin in patients with recurrent or metastatic nanopharyngeal carcinoma. Oral Oncology. 48(5). 441–444. 15 indexed citations
2.
Tung, Shui‐Yi, Dtt Chua, Roger K.C. Ngan, et al.. (2010). Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma. JNCI Journal of the National Cancer Institute. 102(15). 1188–1198. 240 indexed citations
3.
Yau, T.K., Cheuk‐Wai Choi, Esther Ng, et al.. (2010). Delayed presentation of symptomatic breast cancers in Hong Kong: experience in a public cancer centre.. PubMed. 16(5). 373–7. 25 indexed citations
4.
Yau, T.K., Cheuk‐Wai Choi, Henry Sze, Inda Soong, & Anne W.M. Lee. (2009). Should young age be a contra-indication to breast conservation treatment in Chinese women? Twelve-year experience from a public cancer centre in Hong Kong.. PubMed. 15(2). 94–9. 3 indexed citations
5.
Law, Angeline, et al.. (2008). Screening for family members of patients with nasopharyngeal carcinoma—does early detection improve outcome?. Journal of Clinical Oncology. 26(15_suppl). 1512–1512. 1 indexed citations
6.
Yau, T.K., Inda Soong, Ko Ling Chan, et al.. (2007). Clinical Outcome of Breast Conservation Therapy for Breast Cancer in Hong Kong: Prognostic Impact of Ipsilateral Breast Tumor Recurrence and 2005 St. Gallen Risk Categories. International Journal of Radiation Oncology*Biology*Physics. 68(3). 667–672. 10 indexed citations
7.
Yau, T.K., Inda Soong, Ko Ling Chan, et al.. (2007). Evaluation of the prognostic value of 2005 St Gallen risk categories for operated breast cancers in Hong Kong. The Breast. 17(1). 58–63. 6 indexed citations
8.
Yau, T.K., Anne W.M. Lee, E. Pang, et al.. (2006). Treatment of Stage IV(A–B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: Impact of chemotherapy schemes. International Journal of Radiation Oncology*Biology*Physics. 66(4). 1004–1010. 40 indexed citations
9.
Yau, T.K., Anne W.M. Lee, Rebecca M.W. Yeung, et al.. (2006). Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma. Head & Neck. 28(10). 880–887. 38 indexed citations
10.
Tung, Stewart Y., Benny Zee, Daniel T. T. Chua, et al.. (2005). Survival outcome of patients with nasopharyngeal carcinoma with first local failure: A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head & Neck. 27(5). 397–405. 138 indexed citations
11.
Le, Quynh‐Thu, Carol D. Jones, T.K. Yau, et al.. (2005). A Comparison Study of Different PCR Assays in Measuring Circulating Plasma Epstein-Barr Virus DNA Levels in Patients with Nasopharyngeal Carcinoma. Clinical Cancer Research. 11(16). 5700–5707. 79 indexed citations
12.
Sze, Wai-Man, Anne W.M. Lee, T.K. Yau, et al.. (2004). Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control. International Journal of Radiation Oncology*Biology*Physics. 59(1). 21–27. 170 indexed citations
13.
Cheung, Florence, et al.. (2004). Nasopharyngeal intraepithelial lesion: latent Epstein–Barr virus infection with malignant potential. Histopathology. 45(2). 171–179. 16 indexed citations
14.
Soong, Inda, et al.. (2004). Post-mastectomy Radiotherapy after Immediate Autologous Breast Reconstruction in Primary Treatment of Breast Cancers. Clinical Oncology. 16(4). 283–289. 36 indexed citations
16.
Sze, W.M., et al.. (2002). Encouraging early results for advanced stage III-IV nasopharyngeal carcinoma using neoadjuvant-concurrent chemotherapy and accelerated radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 54(2). 287–287. 1 indexed citations
17.
Cheung, Florence, et al.. (1998). Nasopharyngeal carcinoma in situ. Cancer. 83(6). 1069–1073. 15 indexed citations
18.
Yau, T.K., et al.. (1993). Central pontine myelinolysis: Report of two occurrences after cisplatin-containing chemotherapy for nasopharyngeal carcinoma. Clinical Oncology. 5(6). 395–396. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026